DNA Methyltransferase 1: A Potential Gene Therapy Target for Hepatocellular Carcinoma?

Publisher： Karger

E-ISSN： 2296-5262|39|7-8|448-452

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.39, Iss.7-8, 2016-06, pp. : 448-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy

By Jung Yeonjoo   Park Jinah   Kim Tai   Park Jung-Hyun   Jong Hyun-Soon   Im Seock-Ah   Robertson Keith   Bang Yung-Jue   Kim Tae-You  

Journal of Molecular Medicine, Vol. 85, Iss. 10, 2007-10 ,pp. : 1137-1148

Springer Publishing Company

Access to resources Recommend Favorite

Combination Therapy with S-1 and Pegylated Interferon Alpha for Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 75, Iss. 1, 2008-12 ,pp. : 106-113

Karger

Access to resources Recommend Favorite

Association of Genetic Polymorphisms in STAT1 Gene with Increased Risk of Hepatocellular Carcinoma

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 382-388

Karger

Access to resources Recommend Favorite

Epigenetic inactivation of transforming growth factor‐β1 target gene HEYL, a novel tumor suppressor, is involved in the P53‐induced apoptotic pathway in hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 7, 2015-07 ,pp. : 782-793

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibroblast Growth Factor Receptor 1 as a Target for the Therapy of Renal Cell Carcinoma

By  

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 321-331

Karger

Access to resources Recommend Favorite